TrialOpen forum infectious diseases2026

A US Hospital-Perspective Decision-Analytic Model of Once-Weekly Rezafungin Versus Daily Echinocandin Therapy in Hospitalized Adults With Candidemia or Invasive Candidiasis: Potential Cost Savings From Earlier Discharge.

Thomas P Lodise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.